Volitionrx Limited (VNRX) Tops Q2 EPS by 4c

Volitionrx Limited (: VNRX) reported Q2 EPS of ($0.10), $0.04 better than the analyst estimate of ($0.14).

For earnings history and earnings-related data on Volitionrx Limited (VNRX) click here.

You May Also Be Interested In

• VolitionRx Shares Further Details and Video of the DETECSEPS Program Launch in France
• DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2
• Element Solutions (ESI) PT Lowered to $47 at UBS, Buy Rating Maintained